The latest company news and thought leadership from our team
January 11, 2022
Transcarent, a new and different health and care experience company for employees of self-insured employers and their families, announced today a $200 million Series C investment led by Kinnevik and Human Capital, with participation from Ally Bridge Group and leading health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center. The funding round also included participation from existing investors, including General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund, Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures
October 15, 2021
Walmart and Transcarent today announced they would be working together as go-to-market partners for self-insured employers across the country. The agreement allows Transcarent, which offers employees and their dependents a new, different, and better health and care experience, to share Walmart’s everyday low-cost on pharmaceuticals and other services with self-insured employers and their employees for the first time.
September 28, 2021
Transcarent is excited to welcome Erica Davila as General Counsel. Reporting to Transcarent CEO Glen Tullman, Ms. Davila will oversee legal, compliance, and regulatory issues. The Former Zocdoc, Haven, and JPMorgan Chase executive brings extensive legal and regulatory experience in the health care and financial services industries.
September 8, 2021
Transcarent announced today the appointment of Stephanie Peng as Chief Financial Officer. Ms. Peng will scale Transcarent’s financial operations in preparation for rapid market expansion. Ms. Peng is a proven business leader and finance executive with more than two decades of experience leading and scaling category winners in the digital health and technology industries.
September 2, 2021
Transcarent announced today the appointment of Snezana Mahon, Pharm.D., as Chief Operating Officer. Ms. Mahon will report to Transcarent Executive Chairman and Chief Executive Officer, Glen Tullman. Ms. Mahon brings deep expertise in product development, pharmacy benefits management, and value-based care, having spent her career advancing innovative clinical initiatives and utilization management programs at Express Scripts and more recently, Evernorth, a division of Cigna, helping to make the use of prescription medications safer, more affordable, and more accessible for patients.
June 10, 2021
Transcarent, a new and different consumer-directed health and care experience for employees of self-insured employers and their families, today announced a $58 million Series B investment led by General Catalyst and 7wireVentures, with participation from Merck Global Health Innovation Fund, Kleiner Perkins, Leaps by Bayer, GreatPoint Ventures, and Threshold Ventures along with existing investors Alta Partners and Jove Equity Partners.
April 15, 2021
National Benchmark Study Supports BridgeHealth’s High-Value and High-Quality Surgical Focus Against $253 Billion in Medical Claims Paid by Self-Insured Employers
March 18, 2021
Introduces New Transformative Health and Care Platform to Help Improve the Quality and Value of Care, Reduce Waste, and Share Savings Directly with Employees of Self-Insured Employers
January 28, 2021
Mercer’s Former U.S. Clinical Services and Innovation Strategy Leader to drive new consumer-directed platform for employees and risk-sharing for self-insured employers
October 22, 2020
Combined entity will create a better experience and improved outcomes for employees and dependents of self-insured employers by providing greater access, choice, and transparency.